Glycopyrronium Bromide
Glycopyrronium Bromide is a synthetic quaternary ammonium compound widely used in pharmaceutical applications for its anticholinergic properties. It functions by inhibiting acetylcholine at muscarinic receptors, helping to reduce secretions and control smooth muscle activity.
| Packaging |
|---|
| - |
Category
Sectors
Pharma
:quality(80)){kind=logo}
:quality(80)){kind=logo}
:quality(80)){kind=logo}
:quality(80))
What is Glycopyrronium Bromide
Glycopyrronium Bromide is a clinically established active pharmaceutical ingredient (API) known for its strong antimuscarinic activity. Due to its quaternary ammonium structure, it has limited ability to cross the blood–brain barrier, resulting in reduced central nervous system effects compared to other anticholinergics. This makes it particularly suitable for targeted therapeutic applications where peripheral action is required without significant neurological impact.
It is commonly utilised in formulations designed to manage respiratory conditions, including chronic obstructive pulmonary disease (COPD), as well as for reducing excessive salivation and gastric secretions in pre-operative settings. Glycopyrronium Bromide is valued for its stability, predictable pharmacokinetics, and compatibility with various delivery formats such as inhalation powders, injectables, and oral solutions. Its high efficacy and safety profile make it a trusted component in both acute and long-term treatment regimens across healthcare settings.
- High Purity
- Anticholinergic
- GMP
- Pharmaceutical API
- Respiratory Health
- COPD
- Inhalation
- Bronchodilator
- Healthcare Ingredient
Applications & Functionalities
Glycopyrronium Bromide is primarily used in pharmaceutical formulations where anticholinergic activity is required. It acts as a competitive antagonist of muscarinic receptors, effectively reducing involuntary muscle movements and glandular secretions. In respiratory treatments, it functions as a long-acting bronchodilator, helping to relax airway smooth muscles and improve airflow in patients with obstructive lung diseases. Additionally, it is used to manage hypersalivation, reduce gastric secretions during surgery, and support anaesthesia protocols. Its low central nervous system penetration makes it especially effective for treatments requiring minimal sedation or cognitive side effects. The compound is suitable for use in inhalation therapies, injectable solutions, and oral formulations, offering flexibility in product development and delivery systems.
Glycopyrronium Bromide is primarily used in pharmaceutical formulations where anticholinergic activity is required. It acts as a competitive antagonist of muscarinic receptors, effectively reducing involuntary muscle movements and glandular secretions. In respiratory treatments, it functions as a long-acting bronchodilator, helping to relax airway smooth muscles and improve airflow in patients with obstructive lung diseases. Additionally, it is used to manage hypersalivation, reduce gastric secretions during surgery, and support anaesthesia protocols. Its low central nervous system penetration makes it especially effective for treatments requiring minimal sedation or cognitive side effects. The compound is suitable for use in inhalation therapies, injectable solutions, and oral formulations, offering flexibility in product development and delivery systems.
Common applications include:
- COPD treatment
- bronchodilator formulations
- pre-operative medication
- anaesthesia support
- hypersalivation management
- respiratory therapy.
Need specialist support? Let's talk
Speak to one of our specialist team and get the expert support you need.
Get in Touch:quality(80))